This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2001-2015.
Location History:
- Lörrach, DE (2003 - 2006)
- Lorrach, DE (2012)
- Loerrach, DE (2001 - 2015)
Company Filing History:
Years Active: 2001-2015
Title: Innovations in Pharmaceutical Engineering by Oskar Michael Kalb
Introduction
Oskar Michael Kalb, a notable inventor based in Loerrach, Germany, has made significant contributions to the field of pharmaceutical engineering with a total of seven patents to his name. His work primarily focuses on improving drug formulations and enhancing therapeutic effectiveness.
Latest Patents
Among his latest innovations is the "High Drug Load Tablet," which features an active ingredient, Compound I, incorporated in a weight percentage ranging from 30% to 80% of the total tablet weight. This innovative approach aims to optimize the delivery of pharmaceuticals, making treatments more effective and tolerable for patients. Another recent patent involves "Pharmaceutical Compositions Comprising Fluvastatin," which includes HPMC and optionally other excipients, ensuring that these compositions remain colour-stable even after prolonged storage. This enhancement further contributes to the reliability and longevity of pharmaceutical products.
Career Highlights
Oskar Kalb is currently affiliated with Novartis AG, a leading global healthcare company known for its innovative solutions in pharmaceuticals. His role at Novartis enables him to push the boundaries of drug development, ensuring that his inventions can reach a wider audience and have a meaningful impact on public health.
Collaborations
Throughout his career, Oskar has collaborated with esteemed colleagues such as Stephen John Valazza and Jean-Daniel Bonny. These collaborations highlight the importance of teamwork in driving innovation and developing groundbreaking pharmaceutical technologies.
Conclusion
Oskar Michael Kalb's work in pharmaceutical innovations underscores the critical role of inventors in advancing medical science. With his impressive record of patents and collaborations, he continues to lead the charge in transforming the landscape of drug formulation and delivery systems, ultimately benefiting patients worldwide.